4 news items
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
ABVC
18 Apr 24
to registration or qualification under the securities laws of such state or jurisdiction. Contact: Leeds Chow Email
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
ABVC
10 Apr 24
or qualification under the securities laws of such state or jurisdiction. Contact:Leeds ChowEmail: leedschow
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
ABVC
26 Mar 24
or jurisdiction. Contact: Leeds Chow Email: leedschow@ambrivis.com
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
ABVC
14 Mar 24
be unlawful prior to registration or qualification under the securities laws of that state or jurisdiction. Contact: Leeds Chow
- Prev
- 1
- Next